WFDC2 and triple-A syndrome: Patients with AAA who had experienced a MACE had significantly elevated levels of HE4 compared to patients with AAA who had not experienced a MACE (15,955 ± 14,875 vs. 12,922 ± 9101, respectively, p = 0.029) (Table 9).